U

UroGen Pharma, Inc

Develops RTGel-based drug delivery for uro-oncology

Associate Director/Director - Non-Clinical and Translational Research

Translational Research & Bench BiologyConfirmed live in the last 24 hours
Full-timePennsylvania, USANo salary listed

About the Job

Requirements

  • A Ph.D. in cell biology, immunology, virology, or a related discipline.
  • Expertise in tumor immunology and/or virology.
  • At least five years of relevant biotechnology or pharmaceutical industry experience.
  • Experience leading nonclinical and/or translational aspects of cancer drug discovery or development programs.
  • Direct experience drafting nonclinical sections of Investigational New Drug submissions.
  • Demonstrated success managing outsourced research relationships.
  • Strong understanding of nonclinical studies and regulatory requirements needed to advance programs into and through clinical development.
  • Ability to integrate multidisciplinary data into clear, evidence-based recommendations.
  • Ability and willingness to work regularly in person in Philadelphia.

Responsibilities

  • Lead nonclinical and translational research activities aligned with program, clinical development, and regulatory objectives.
  • Design and oversee in vitro and in vivo studies evaluating mechanism of action, pharmacology, efficacy, and/or biodistribution.
  • Select and manage vendors and consultants, including study design, protocol development, data review, troubleshooting, and final reports.
  • Lead preparation of nonclinical sections of Investigational New Drug submissions and other regulatory documents, and partner with nonclinical safety/toxicology to integrate findings.
  • Evaluate clinical pharmacodynamic and predictive biomarker data to assess biological activity, inform dosing regimen and/or patient selection, and guide program decisions.
  • Support scientific due diligence and evaluation of licensing, partnering, and other business development opportunities.

Desired Qualifications

  • Experience designing and characterizing novel oncolytic viruses and/or other novel therapeutics.
  • Experience building laboratory capabilities.

About the Company

UroGen Pharma, Inc

Develops RTGel-based drug delivery for uro-oncology

UroGen Pharma develops RTGel-based drug-delivery therapies for urothelial and specialty cancers, commercializing products like Jelmyto and ZUSDURI and advancing a pipeline that includes UGN-102, UGN-103, UGN-104, and UGN-301. Its RTGel platform is liquid at cool temperatures and gels at body temperature, allowing chemotherapy to stay at the treatment site longer for local, sustained exposure. The company differentiates itself by delivering established chemotherapy directly to the disease site to reduce systemic exposure and by building a multi-product portfolio focused on urothelial cancers. Its goal is to improve local treatment outcomes and grow a diversified, globally commercial portfolio through ongoing clinical development and partnerships.

Company size
201-500
Company stage
IPO
Headquarters
Princeton, NJ
Founded
2004

Recently Posted Jobs

Explore more opportunities at UroGen Pharma, Inc

See more jobs